Chemical Compound
2-Formyl-cefpodoxime proxetil
CAS Registry Number
96680-30-7
Primary Record
2-Formyl-cefpodoxime proxetil
- In stock
- 5,197 g
- Purity
- 99.3 %
- CAS
- 96680-30-7
Compound Identifiers & Properties
- CAS
- 96680-30-7
- PubChem CID
- 13421809
- SMILES
- CC(C)OC(=O)OC(C)OC(=O)C1=C(CS[C@H]2N1C(=O)[C@H]2NC(=O)/C(=N\OC)/C3=CSC(=N3)NC=O)COC
- Canonical SMILES
- COCC1=C(C(=O)OC(C)OC(=O)OC(C)C)N2C(=O)[C@@H](NC(=O)/C(=N\OC)c3csc(NC=O)n3)[C@H]2SC1
Names & Synonyms
- 2-Formyl-cefpodoxime proxetil
- 9J43NDE6TC
- N-Formyl cefpodoxime proxetil
- RefChem:202150
- Cefpodoxime Proxetil EP Impurity F
- UNII-9J43NDE6TC
- 96680-30-7
- Cefpodoxime Proxetil Impurity F
- Cefpodoxime proxetil impurity F [EP]
- KBBPBOYVHDSXFI-KMMUMHRISA-N
- DTXSID701098544
- C22H27N5O10S2
- J243.114I
- CEFPODOXIME PROXETIL IMPURITY F [EP IMPURITY]
- CEFPODOXIME PROXETIL IMPURITY F (EP IMPURITY)
- 1-propan-2-yloxycarbonyloxyethyl (6R,7R)-7-[[(2Z)-2-(2-formamido-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2Z)-2-(2-(formylamino)-4-thiazolyl)-2-(methoxyimino)acetyl)amino)-3-(methoxymethyl)-8-oxo-, 1-(((1-methylethoxy)carbonyl)oxy)ethyl ester, (6R,7R)-
- (1RS)-1-(((1-Methylethoxy)carbonyl)oxy)ethyl (6R,7R)-7-(((2Z)-2-((2-formylamino)thiazol-4-yl)-2-(methoxyimino)acetyl)amino)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
- 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2Z)-(2-(formylamino)-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(methoxymethyl)-8-oxo-, 1-(((1-methylethoxy)carbonyl)oxy)ethyl ester, (6R,7R)-
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-2-[2-(formylamino)-4-thiazolyl]-2-(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-, 1-[[(1-methylethoxy)carbonyl]oxy]ethyl ester, (6R,7R)-
- (6R,6beta)-7alpha-[[2-(Formylamino)thiazol-4-yl][(Z)-methoxyimino]acetylamino]-3-methoxymethyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 1-(isopropoxycarbonyloxy)ethyl ester
- (6R,7R)-1-((isopropoxycarbonyl)oxy)ethyl 7-((Z)-2-(2-formamidothiazol-4-yl)-2-(methoxyimino)acetamido)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- (6R,7R)-7-[[(2Z)-2-[2-(Formylamino)-4-thiazolyl]-2-(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid;1-[[(1-methylethoxy)carbonyl]oxy]ethyl Ester; [6R-[6alpha,7beta(Z)]]-7-[[[2-(Formylamino)-4-thiazolyl](methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid; 1-[[(1-methylethoxy)carbonyl]oxy]ethyl Ester; 1-[[(1-Methylethoxy)carbonyl]oxy]ethyl; (6R,7R)-7-[[(2Z)-2-[2-(formylamino)-4-thiazolyl]-2-(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; Cefpodoxime Proxetil EP Impurity F; 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-2-[2-(formylamino)-4-thiazolyl]-2-(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-, 1-[[(1-methylethoxy)carbonyl]oxy]ethyl ester, (6R,7R)-
- 1-((isopropoxycarbonyl)oxy)ethyl-(6R,7R)-7-((Z)-2-(2-formamidothiazol-4-yl)-2-(methoxyimino)acetamido)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- 1-[[(1-Methylethoxy)carbonyl]oxy]ethyl (6R,7R)-7-[[(2Z)-2-[2-(formylamino)-4-thiazolyl]-2-(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- 1-{[(propan-2-yloxy)carbonyl]oxy}ethyl (6R,7R)-7-[(2Z)-2-(2-formamido-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- 1-isopropoxycarbonyloxyethyl (6R,7R)-7-[[(2Z)-2-(2-formamidothiazol-4-yl)-2-methoxyimino-acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- 619-239-2
- N/A